Onyx Scientific

Exhibitor

Onyx Scientific, the CDMO division of Ipca Laboratories, has specialized in small molecule drug substance development and manufacturing for 25 years. From our MHRA-licensed facilities in the UK, we provide seamless support for early development for candidate APIs, clinical phase production, and commercial supply.

Our dedicated solid-state and analytical chemistry teams accelerate development timelines, offering both integrated services and full-service outsourced solutions to complement your in-house efforts. With extensive expertise in early-stage development, we adopt a pragmatic, fit-for-purpose approach that prioritizes rapid process development while paving the way for future GMP campaigns.

For projects requiring scale-up beyond Phase II, we ensure continuity through seamless transitions within our global network, leveraging sister sites and expert teams in the USA and India to meet your long-term manufacturing needs.



website

Get involved at World Orphan Drug Congress Europe 2025

 

 

TO SPONSOR


Kieran Duffin

Kieran.Duffin@terrapinn.com

 

Adam Mayar
Adam.Mayar@terrapinn.com

 

TO SPEAK


Abdu Kauroo
Abdu.Kauroo@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.